HomeFacultyAimee Edinger

Aimee Edinger

Aimee Edinger, VMD, Ph.D.
Associate Professor

2128 Natural Sciences I
University of California Irvine
Irvine, CA 92697

Email: aedinger@uci.edu
Lab Homepage

Apoptosis, cancer, intracellular trafficking

The Edinger Lab studies how cell growth and survival is regulated by growth factors at the level of nutrient transporter expression. This research has important implications for cancer biology and treatment.

Role of nutrient transporter proteins in growth control and cancer

My lab is investigating the hypothesis that mammalian cell growth is regulated at the level of nutrient transporter expression. Although the bloodstream constantly supplies mammalian cells with nutrients, signal transduction cascades regulate access to these nutrients by modulating the expression of nutrient transport systems in the cell membrane. By identifying the proteins regulating nutrient transporter expression and trafficking, we expect to gain insight into normal cell biology and identify novel therapeutic targets in cancer. Normal cells become quiescent when restricted for nutrients. Cancer cells, on the other hand, have activated oncogenes that promote growth regardless of the extracellular conditions and deleted the tumor suppressor proteins that allow them to switch to catabolism. Thus, drugs that limit nutrient transporter expression are likely to be selectively toxic to tumor cells.

In order to pursue this idea, my lab has amassed expertise and reagents that allow us to examine how alterations in bioenergetics characteristic of cancer cells interact with conditions that alter nutrient transporter expression. One area of particular interest is autophagy—the adaptive cellular response to the starvation induced by nutrient transporter loss. Through autophagy, (literally, eating one’s self) cells recycle their constituents to provide essential nutrients. We have shown that cells undergoing autophagy in the presence of abundant extracellular nutrients are often cells that have reduced nutrient transporter expression. We have also found that blocking apoptosis (programmed cell death) does not stop nutrient transporter loss from killing cells. The ability of nutrient transporter down-regulation to kill cells necrotically could be useful in cancer therapy as most tumor cells have disabled apoptotic pathways. These studies are also highly relevant to the fields of diabetes and aging.

How is nutrient transporter turnover regulated?

Most scientists are surprised that very little is known about the signals that regulate nutrient transporter expression and trafficking. Although the trafficking of the transferrin receptor (TfR), the LDL receptor (LDLR), and GLUT4 (the insulin sensitive glucose transporter found in adipose and muscle tissue) has been exhaustively studied, amino acid transporters and the broadly expressed GLUT1 are not nearly as well studied. Because the TfR and LDLR deliver their cargo by endocytosis, their regulation is likely to be very different from channel-type transporters like amino acid transporters and GLUT1. Studies of GLUT4 may provide more clues, but this protein trafficks in and out of a special compartment in the cytoplasm and is likely to utilize pathways distinct from those travelled by the vast majority of transporters. My lab has identified signal transduction cascades including the serine-threonine kinase Akt and mammalian TOR (mTOR) as key players in this process. In addition to these kinases, we have identified a downstream regulator of nutrient transporter expression, the small GTPase Rab7. Rab7 promotes membrane fusion events between late endsomes and lysosomes, including those required for nutrient transporter degradation. When Rab7 function is disrupted, it has a dramatic effect on the ability of growth factors to regulate cell growth and survival. Recently, we have made the exciting discovery that ceramide kills mammalian cells by causing a rapid and profound down-regulation of nutrient transporter proteins. Ceramide activates a variety of signaling molecules, and we are investigating which ones might be responsible for the effect of ceramide on nutrient transporter proteins. As ceramide has been linked to cell cycle arrest, death, differentiation, and senescence, our findings may have broad implications for cell biology.

Recent Publications

  • Selwan E and AL Edinger (2017).  Branched chain amino acid metabolism and cancer: the importance of keeping things in context. Translational Cancer Research, 6(Suppl 3):S578-S584. doi: 10.21037/tcr.2017.05.05 (commentary on Science 353:1161-5 (2016).
  • Kallenborn-Gerhardt W, Möser CV, Lorenz JE, Steger M, Heidler J, Scheving R, Petersen J, Kennel L, Flauaus C, Lu R, Edinger AL, Tegeder I, Geisslinger G, Heide H, Wittig I, PhD, and Schmidtko A (2017).  Rab7 – a novel redox target that modulates inflammatory pain processing. PAIN, in press. PMID: 28394828
  • McCracken AN, McMonigle RJ, Tessier J, Fransson R, Perryman MS, Chen B, Keebaugh A, Selwan E, Barr SA, Kim SM, Roy SG, Liu G, Fallegger D, Sernissi L, Brandt C, Moitessier N, Snider AJ, Clare S, Müschen M, Huwiler A, Kleinman MT, Hanessian S, and AL Edinger (2017).  Phosphorylation of a constrained azacyclic FTY720 analog enhances anti-leukemic activity without inducing S1P receptor activation. Leukemia. 31(3):669-677. PMID: 27573555
  • Jaber N, Mohd-Naim N, Wang Z, DeLeon JL, Kim SM, Zhong H, Sheshadri N, Dou Z, Edinger AL, Du G, Braga VMM, and W-X Zong (2016).  Vps34 regulates Rab7 and late endocytic trafficking through recruitment of the GTPase activating protein Armus. Journal of Cell Science, 129(23):4424-4435.
  • Kim SM, Roy SG, Chen B, Nguyen T, McMonigle RJ, McCracken AN, Finicle BT, Zhang Y, Kofuji S, Hou J, Selwan E, Nguyen T, Ravi A, Ramirez MU, Wiher T, Guenther GG, Kono M, Sasaki AT, Weisman LS, Potma EO, Tromberg BJ, Hanessian S, and AL Edinger (2016). Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways. Journal of Clinical Investigation 126(11):4088-4108. PMID: 27669461
  • Perryman M, Tessier J, Wiher T, O’Donoghue H, McCracken AN, Kim SM, Nguyen GD, Simitan GS, Viana M, Rafelski S, Edinger AL# and S Hanessian# (2016).  Effects of stereochemistry, saturation, and hydrocarbon chain length on the ability of constrained azacyclic sphingolipids to trigger nutrient transporter down-regulation, vacuolation, and cancer cell death. (# = co-corresponding authors) Bioorganic and Medicinal Chemistry 24:4390-7. PMID: 27475534
  • Walker WP, Oehlerb A, Edinger AL, Wagner K-U, and TM Gunn (2016). Oligodendroglial deletion of ESCRT-I component TSG101 causes spongiform encephalopathy.  Biology of the Cell, 108(11): 324-337.  PMID: 27406702.
  • Safaiyan S, Snaidero N, Edinger AL, Jung S, M Simons (2016). Age-related myelin fragmentation overwhelms the clearance function of microglia during normal aging. Nature Neuroscience 19:995-8. PMID: 27294511
  • Klionsky D . . . Edinger AL . . . et al. (2016). Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12(1):1-222. PMC4835977
  • Selwan EM, Finicle BT, Kim SM, and AL Edinger (2016). Attacking the supply wagons to starve cancer cells to death.  FEBS Lett. 590:885-907. PMID: 26938658
  • Chen B*, Roy SG*, McMonigle RJ, Keebaugh A, McCracken AN, Selwan E, Fransson R, Fallegger D, Huwiler A, Kleinman MT, Edinger AL# and S Hanessian# (2016).  Azacyclic FTY720 Analogues that Limit Nutrient Transporter Expression but Lack S1P Receptor Activity and Negative Chronotropic Effects Offer a Novel and Effective Strategy to Kill Cancer Cells in vivo.  ACS Chemical Biology,11(2):409-14. (* = co-first authors, # = co-corresponding authors)
  • McCracken AN and AL Edinger (2015).  Targeting cancer metabolism at the plasma membrane by limiting amino acid access through SLC6A14. Biochem. J., 470(3):e17-9.
  • Holden JK, Kang S, Beasley FC, Cinelli MA, Li h, Roy SG, Dejam D, Edinger AL, Nizet V, Silverman RB, and TL Poulos (2015).  Nitric Oxide Synthase as a Target for Methicillin Resistant Staphylococcus aureus. Chemistry & Biology 22:785-92. PMID: 26091171
  • Pone EJ, Lam T, Edinger AL, Xu Z, and P Casali (2015).  B Cell Rab7 Mediates Induction of AID Expression and Class-switching in T-dependent and T-independent Antibody Responses.  Journal of Immunology 194:3065-78. PMID: 25740947
  • Guenther GG*, Liu G*, Ramirez MU, McMonigle RJ, McCracken AN, Kim SM, Joo Y, Ushach I, Nguyen NL, and AL Edinger (2014).  Loss of TSC2 confers resistance to ceramide and nutrient deprivation.  Oncogene 33:1776-1787. PMID: 23604129
  • Fransson R*, McCracken AN*, Chen B, McMonigle RJ, Edinger AL# and S Hanessian#.  Design, Synthesis, and Anti-leukemic Activity of Stereochemically Defined Constrained Analogs of FTY720 (Gilenya). ACS Medicinal Chemistry Letters, in press. (* = co-first authors, # = co-corresponding authors)
  • Guenther GG*, Liu G*, Ramirez MU, McMonigle RJ, McCracken AN, Kim SM, Joo Y, Ushach I, Nguyen NL, and AL Edinger (2013).  Loss of TSC2 confers resistance to ceramide and nutrient deprivation.  Oncogene (ePub ahead of print).
  • Roy SG, Stevens MW, So L and AL Edinger (2013).  Reciprocal effects of Rab7 deletion in activated and neglected T cells.  Autophagy vol. 9, issue 7 (ePub ahead of print).
  • McCracken AN and AL Edinger (2013). Nutrient transporters: the Achilles’ heel of anabolism.  Trends in Endocrinology and Metabolism 24:200-8.
  • Klionsky DJ . . . Edinger AL . . . (and others) (2012).  Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.  Autophagy 8:445-544.
  • Chen J, Narayan S, Edinger AL, and MJ Bennett (2012).  Flow injection tandem mass spectrometric measurement of ceramides of multiple chain lengths in biological samples.  J Chromatogr B Analyt Technol Biomed Life Sci. 883-884: 136-140.
  • Romero Rosales K, Singh G, Wu K, Chen J, Lilly MB, Peralta ER, Janes MR, Siskind LJ, Bennett MJ, Fruman DA, and AL Edinger (2011).  Sphingolipid-based drugs selectively kill cancer cells by down-regulating nutrient transporter proteins.  Biochem. J. 439:299-311.
  • AL Edinger (2011). Unequal in the absence of death: A novel screen identifies cytotoxic compounds selective for cells with activated Akt. Cancer Biol Ther. 10:1262-5.
  • Walsh CM and AL Edinger (2010). The complex interplay between autophagy, apoptosis, and necrotic signals promotes T-cell homeostasis. Immunol. Rev. 236:95-109.
  • Peralta EP, Martin BC, and AL Edinger (2010). TBC1D15 is a selective Rab7 GTPase activating protein but mammalian Vps39 does not modulate Rab7 GTP binding status. J. Biol. Chem. 285:16814-21.http://www.ncbi.nlm.nih.gov/pubmed/20363736 This paper identifies proteins that regulate lysosomal dynamics and shows that they modulate growth factor dependence.
  • Romero KR, Peralta EP, Guenther GG, Wong SY, and AL Edinger (2009). Rab7 activation by growth factor withdrawal contributes to the induction of apoptosis. Molec. Biol. of the Cell 20:2831-40.http://www.ncbi.nlm.nih.gov/pubmed/19386765?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=1 This paper demonstrates that Rab7 activity is regulated by growth factors and that activating Rab7 can kill cells.
  • AL Edinger (2008). Starvation in the midst of plenty: making sense of ceramide-induced autophagy by analyzing nutrient transporter expression. Biochem Soc Trans. 2009 Feb;37(Pt 1):253-8. http://www.ncbi.nlm.nih.gov/pubmed/19143642?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=4This review helps to place our recent studies of the effect of ceramide on nutrient transporter expression in context.
  • Guenther GG, Peralta EP, Romero KR, Wong SY, Siskind, LJ and AL Edinger (2008). Ceramide starves cells to death by down-regulating nutrient transporter proteins. Proc. Natl. Acad. Sci. 105, 17402–17407. http://www.ncbi.nlm.nih.gov/pubmed/18981422?ordinalpos=1itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSumThis paper establishes for the first time that ceramide kills cells through a bioenergetic mechanism.
  • Edinger, AL (2007). Controlling cell growth and survival through regulated nutrient transporter expression. Biochem. J. 406:1-12.http://www.ncbi.nlm.nih.gov/pubmed/17645414?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSumComprehensive review of regulated nutrient transporter expression and its role in cellular growth control.

Faculty Log In